Neutral
[DEF 14A] Milestone Pharmaceuticals Inc. Definitive Proxy Statement
Milestone Pharmaceuticals Inc. has filed its definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Shareholders, to be held virtually on...